Founded
Address
ARCH Venture Partners
1700 Owens Street
Suite 535
San Francisco, CA 94158
United States
Phone
Website
Industry
Recent investment activity
KANDO id: 30599
Corporate information
Official name
ARCH Venture Partners LP
Registration country
Official identities
US CIK 0001666306
Company type
Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startupFunds managed
| Fund | Type | Vintage | Currency | Committed capital | IRR | x |
|---|---|---|---|---|---|---|
| ARCH Venture Fund IX LP | Venture | 2016 | USD | 408,400,000 | ||
| ARCH Venture Fund VIII Overage LP | Venture | 2015 | USD | 150,000,000 | ||
| ARCH Venture Fund VIII LP | Venture | 2014 | USD | 400,532,000 | ||
| ARCH Venture Fund VII LP | Venture | 2007 | 40.69 % | 3.99 x | ||
| ARCH Venture Fund VI LP | Venture | 2003 | 3.49 % | 1.09 x | ||
| ARCH Venture Fund V LP | Venture | 2000 | ||||
| ARCH Venture Partners IV | Venture | 1999 | USD | 175,000,000 | ||
| ARCH Venture Partners III | Venture | 1997 | USD | 107,000,000 | ||
| ARCH Venture Partners II | Venture | 1993 |
Funding rounds
| Investor | Profile | Country | |
|---|---|---|---|
|
Chevron Technology Ventures LLC (CTV) | Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron |
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 134| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
Achaogen Inc | Develops solutions to the problem of drug resistance | N/A Initial investment | |||
| Acylin Therapeutics Inc | N/A | |||||
| Adesto Technologies Corp | Fabless semiconductor manufacturer | N/A | ||||
| Adolor Corp | N/A | |||||
| Agios Pharmaceuticals Inc | N/A | |||||
| Ahura Scientific Inc | N/A | |||||
| Alfalight Inc | Designer and manufacturer of high-power diode lasers for the industrial, defense and telecommunications markets. | N/A | ||||
| ALIS Corp | N/A | |||||
| Allozyne Inc | N/A | |||||
| Alnylam Pharmaceuticals Inc | N/A | |||||
| AmberWave Systems Corp | N/A | |||||
| Apoptos Inc | N/A | |||||
| Apropos Technology Inc | N/A | |||||
| Array BioPharma Inc | N/A | |||||
| Artificial Muscle Inc | N/A | |||||
| Aveso Inc | N/A | |||||
| Aviron Inc | N/A | |||||
| Bind Biosciences Inc | Developer of “smart” therapeutic targeted nano-particles capable of differential delivery and controlled drug release to diseased tissue | Series B | ||||
| Bluebird Bio Inc | Developer of an innovative gene therapies for severe genetic disorders | Series D | ||||
| Bluebird Bio Inc | Developer of an innovative gene therapies for severe genetic disorders | Venture | ||||
| Boreal Genomics Inc | High performance nucleic acid purification, enrichment, and sequence detection. | N/A Initial investment | ||||
| Caliper Life Sciences Inc | N/A | |||||
| Callisto Software Inc | N/A | |||||
|
Cambrios Technologies Corp (Cambrios Advanced Materials) | Developer of proprietary nanostructured electronic materials for the display industry | Series D | |||
|
|
Cambrios Technologies Corp (Cambrios Advanced Materials) | Developer of proprietary nanostructured electronic materials for the display industry | Series B |
Team
| Employee | Position | ||
|---|---|---|---|
| Clinton Bybee (founder) | |||
| Keith Crandell (founder) | |||
| Robert Nelsen (founder) | |||
| Kristina Burow | |||
| David Cruikshank | |||
| Steven Gillis | |||
| Edgar Hotard | |||
| Ajit Medhekar | |||
| Paul Thurk |
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
|
Scott Minick | Bind Biosciences Inc | ||
|
|
Scott Minick | Delin Ventures |